Integra LifeSciences Holdings Corporation. (NASDAQ:IART) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET
Company Participants
Chris Ward - Senior Director, Investor Relations
Jan De Witte - President & Chief Executive Officer
Carrie Anderson - Chief Financial Officer
Conference Call Participants
Ryan Zimmerman - BTIG
David Turkaly - JPM
Vik Chopra - Wells Fargo
Matthew Taylor - Jefferies
Steve Lichtman - Oppenheimer
Drew Ranieri - Morgan Stanley
Richard Newitter - Truist
Operator
Hello and welcome to the Integra LifeScience Third Quarter 2022 Financial Results. My name is Caroline and I’ll be your co-ordinator for today’s event. Please note this call is being recorded. For the duration of the call your lines will be on listen-only. However, you’ll have the opportunity to ask for questions at the end of the call.
[Operator Instructions] I will now hand over the call to your host Chris Ward, Senior Director, Investor Relations to begin today’s conference. Thank you.
Chris Ward
Thank you, Caroline. Good morning and thank you for joining Integra LifeSciences third quarter 2022 earnings conference call. Joining me on the call are Jan De Witte, President and Chief Executive Officer, Carrie Anderson, Chief Financial Officer.
Earlier today, we issued a press release announcing our third quarter 2022 financial results. The release and corresponding earnings presentation, which we will feature during the call, are available at integralife.com under Investors, Events & Presentations and the file named Third Quarter 2022 Earnings Call Presentation.
Before we begin, I would like to remind you that many of the statements made during this call may be considered forward-looking statements. Factors that could cause actual results to differ materially are discussed in the Company' Exchange Act Report filed with the SEC and in the release.
Also, in our prepared remarks, we'll make reference to both reported and organic revenue growth. Organic revenue growth excludes the effects of foreign currency; acquisitions, divestitures, as well as discontinued products. Unless otherwise stated, all disaggregated and franchise-level reporting revenue growth rates are based on organic performance.
And lastly, our comments today will include certain non-GAAP financial measures. Reconciliations of any non-GAAP financial measures can be found in today's press release, which is an exhibit to Integra's current report on Form 8-K filed today with the SEC.
And with that, I will turn the call over to Jan.
Jan De Witte
Thank you, Chris. And good morning everyone. Let me start by reviewing our third quarter and year-to-date business highlights on slide four. We'll come back to Integra’s performance over the past nine months. We started the year strong the second quarter building nicely from our first quarter momentum. And despite choppy waters in the macro environment and disruptions within our supply chain, we capitalized on the steady recovery of procedures in our markets, while protecting our profitability in an inflationary environment.